Cargando…

Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study

PURPOSE: This retrospective study evaluated our hypothesis that high tumor budding (≥10 buds) may help determine the appropriate T category for more accurate staging of intrahepatic cholangiocarcinoma (ICC). METHODS: We analyzed the clinical and histopathologic data of 235 consecutive patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosaka, Hisashi, Ishida, Mitsuaki, Ueno, Masaki, Komeda, Koji, Hokutou, Daisuke, Iida, Hiroya, Hirokawa, Fumitoshi, Matsui, Kosuke, Sekimoto, Mitsugu, Kaibori, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831894/ https://www.ncbi.nlm.nih.gov/pubmed/36643363 http://dx.doi.org/10.1002/ags3.12605

Ejemplares similares

The Impact of a Preoperative Staging System on Accurate Prediction of Prognosis in Intrahepatic Cholangiocarcinoma
por: Kosaka, Hisashi, et al.
Publicado: (2022)

Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study
por: Kaibori, Masaki, et al.
Publicado: (2022)

Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan
por: Kaibori, Masaki, et al.
Publicado: (2022)

Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
por: Kosaka, Hisashi, et al.
Publicado: (2021)

Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
por: Yamamoto, Hidekazu, et al.
Publicado: (2023)

Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma
por: Kaibori, Masaki, et al.
Publicado: (2021)

The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma
por: Kaibori, Masaki, et al.
Publicado: (2021)

Near-Infrared Fluorescence Imaging and Photodynamic Therapy for Liver Tumors
por: Kaibori, Masaki, et al.
Publicado: (2021)

Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period
por: Kaibori, Masaki, et al.
Publicado: (2022)

Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases
por: Kaibori, Masaki, et al.
Publicado: (2022)

New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study
por: Iida, Hiroya, et al.
Publicado: (2020)

Risk factors for incisional hernia according to different wound sites after open hepatectomy using combinations of vertical and horizontal incisions: A multicenter cohort study
por: Iida, Hiroya, et al.
Publicado: (2021)

The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy
por: Kaibori, Masaki, et al.
Publicado: (2023)

Assessing the feasibility of clinicopathological features of hepatic resection for hepatocellular carcinoma in patients over 80 years of age
por: Iida, Hiroya, et al.
Publicado: (2017)

Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis
por: Iida, Hiroya, et al.
Publicado: (2018)

Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy
por: Kaibori, Masaki, et al.
Publicado: (2022)

Efficacy of Nanofiber Sheets Incorporating Lenvatinib in a Hepatocellular Carcinoma Xenograft Model
por: Yoshida, Terufumi, et al.
Publicado: (2022)

Effect of hydrogen gas inhalation on patient QOL after hepatectomy: protocol for a randomized controlled trial
por: Kaibori, Masaki, et al.
Publicado: (2021)

Resection for Primary Retroperitoneal Serous Adenocarcinoma and Liver Metastasis
por: Nakatake, Richi, et al.
Publicado: (2018)

Theranostics Using Indocyanine Green Lactosomes
por: Kaibori, Masaki, et al.
Publicado: (2022)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma
por: Hung, Tsai‐Hsien, et al.
Publicado: (2021)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)

Activities of daily living after surgery among older patients with gastrointestinal and hepatobiliary-pancreatic cancers: a retrospective observational study using nationwide health services utilisation data from Japan
por: Okuyama, Ayako, et al.
Publicado: (2023)

Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
por: Sakaguchi, Tatsuma, et al.
Publicado: (2022)

Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
por: Tsujie, Masanori, et al.
Publicado: (2021)

Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
por: Tsujie, Masanori, et al.
Publicado: (2021)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models
por: Hatta, Masahiko, et al.
Publicado: (2022)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Hepatectomy in a case of hepatocellular carcinoma with constitutional indocyanine green excretory defect
por: Nakatake, Richi, et al.
Publicado: (2018)

Update on perioperative management of patients undergoing surgery for liver cancer
por: Kaibori, Masaki, et al.
Publicado: (2021)

Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models
por: Kotsuka, Masaya, et al.
Publicado: (2022)

Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives
por: Kuwatani, Masaki, et al.
Publicado: (2023)

Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: López-López, Victor, et al.
Publicado: (2018)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_u84pkmusght6n46nq2632k6vn7